New Jersey A 4852: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Status: Approved P.L.2026, c.40. (as of 2026-07-08)

State: New Jersey · Session: 222 · Bill: A 4852

Sponsors: Katz, Andrea, Sweeney, Marisa, Kearney, Vincent M., Tully, Chris, Vitale, Joseph F., Gopal, Vin, Mukherji, Raj, Karabinchak, Robert J., Donlon, Margie, M.D.

View New Jersey A 4852 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.